,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,421,1,3,,17389285,11883,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
1,426,1,2,,17389285,11883,Inconclusive,,,,,Cell Viability - Jurkat,Confirmatory,,
2,427,1,1,,17389285,11883,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
3,433,1,1,,17389285,11883,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
4,434,1,2,,17389285,11883,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
5,435,1,2,,17389285,11883,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
6,445,3,1,,17389285,11883,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
7,530,1,1,,17389285,11883,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
8,540,1,1,,17389285,11883,Inconclusive,,,,,Cell Viability - N2a,Confirmatory,,
9,541,1,1,,17389285,11883,Active,,,,,Cell Viability - NIH 3T3,Confirmatory,,
10,542,1,1,,17389285,11883,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
11,543,1,1,,17389285,11883,Inconclusive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
12,544,2,1,,17389285,11883,Inactive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
13,545,1,1,,17389285,11883,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
14,546,1,1,,17389285,11883,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
15,584,1,3,,17389285,11883,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
16,585,1,4,,17389285,11883,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
17,595,1,3,,17389285,11883,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
18,596,1,2,,17389285,11883,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
19,603,1,2,,17389285,11883,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
20,605,1,2,,17389285,11883,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
21,654,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
22,655,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
23,656,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
24,657,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
25,658,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
26,659,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
27,660,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
28,661,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
29,662,1,1,,17389285,11883,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
30,663,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
31,664,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
32,665,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
33,666,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
34,667,1,1,,17389285,11883,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
35,875,1,2,,17389285,11883,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
36,880,2,1,,17389285,11883,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
37,880,2,1,,17389285,11883,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
38,881,2,2,,17389285,11883,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
39,884,1,2,,17389285,11883,Inconclusive,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
40,885,1,2,,17389285,11883,Inactive,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
41,886,1,2,,17389285,11883,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
42,886,1,2,,17389285,11883,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
43,887,1,2,,17389285,11883,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
44,889,1,3,,17389285,11883,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
45,892,1,2,,17389285,11883,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
46,893,1,2,,17389285,11883,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
47,893,1,2,,17389285,11883,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
48,894,2,1,,17389285,11883,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
49,900,1,3,,17389285,11883,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
50,902,1,2,,17389285,11883,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
51,912,1,2,,17389285,11883,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
52,921,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
53,923,1,2,,17389285,11883,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
54,924,1,2,,17389285,11883,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
55,925,1,2,,17389285,11883,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
56,926,1,2,,17389285,11883,Inconclusive,38016895.0,7253.0,15.8489,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
57,938,1,2,,17389285,11883,Inactive,38016895.0,7253.0,15.8489,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
58,946,1,2,,17389285,11883,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
59,947,1,2,,17389285,11883,Inconclusive,,,0.7943,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
60,948,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
61,955,1,2,,17389285,11883,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
62,960,1,2,,17389285,11883,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
63,961,1,2,,17389285,11883,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
64,962,1,2,,17389285,11883,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
65,963,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
66,964,1,2,,17389285,11883,Inconclusive,,,12.5893,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
67,965,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
68,966,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
69,967,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
70,968,1,2,,17389285,11883,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-009,Confirmatory,,
71,969,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
72,970,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-013,Confirmatory,,
73,971,1,2,,17389285,11883,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-015,Confirmatory,,
74,972,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-017,Confirmatory,,
75,973,1,2,,17389285,11883,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-019,Confirmatory,,
76,974,1,2,,17389285,11883,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-021,Confirmatory,,
77,975,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
78,976,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
79,977,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
80,978,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
81,979,1,2,,17389285,11883,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-007,Confirmatory,,
82,980,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
83,981,1,2,,17389285,11883,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-010,Confirmatory,,
84,982,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
85,983,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
86,984,1,2,,17389285,11883,Inconclusive,,,125.89299999999999,Potency,Cell Viability - LYMP2-016,Confirmatory,,
87,985,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
88,986,1,2,,17389285,11883,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-020,Confirmatory,,
89,987,1,2,,17389285,11883,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-022,Confirmatory,,
90,988,1,2,,17389285,11883,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-024,Confirmatory,,
91,989,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
92,993,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
93,994,1,2,,17389285,11883,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
94,995,1,2,,17389285,11883,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
95,1030,2,1,,17389285,11883,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
96,1452,1,1,,17389285,11883,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
97,1457,1,1,,17389285,11883,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
98,1458,1,1,,17389285,11883,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
99,1469,1,1,,17389285,11883,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
100,1469,1,1,,26752941,11883,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
101,1471,2,1,,17389285,11883,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
102,1476,2,1,,17389285,11883,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
103,1477,1,1,,17389285,11883,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
104,1478,2,1,,17389285,11883,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
105,1479,1,2,,17389285,11883,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
106,1479,1,2,,26752941,11883,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
107,1948,1,1,,17389285,11883,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
108,2101,1,1,,17389285,11883,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
109,2107,1,1,,17389285,11883,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
110,2112,1,1,,17389285,11883,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
111,2120,1,1,,17389285,11883,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
112,2517,2,1,,17389285,11883,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
113,2546,1,1,,17389285,11883,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
114,2549,1,1,,17389285,11883,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
115,2551,1,1,,17389285,11883,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
116,485290,1,1,,17389285,11883,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
117,588513,1,1,,17389285,11883,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
118,588513,1,1,,26752941,11883,Inconclusive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
119,588514,1,1,,17389285,11883,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
120,588514,1,1,,26752941,11883,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
121,588515,1,1,,17389285,11883,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
122,588515,1,1,,26752941,11883,Inconclusive,124375976.0,367.0,15.8489,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
123,588516,1,1,,17389285,11883,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
124,588516,1,1,,26752941,11883,Inconclusive,124375976.0,367.0,44.6684,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
125,588526,1,1,,17389285,11883,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
126,588526,1,1,,26752941,11883,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
127,588527,1,1,,17389285,11883,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
128,588527,1,1,,26752941,11883,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
129,588532,1,1,,17389285,11883,Inconclusive,311348376.0,2908.0,28.1838,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
130,588532,1,1,,26752941,11883,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
131,588533,1,1,,17389285,11883,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
132,588533,1,1,,26752941,11883,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
133,588534,1,1,,17389285,11883,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
134,588534,1,1,,26752941,11883,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
135,588535,1,1,,17389285,11883,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
136,588535,1,1,,26752941,11883,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
137,588536,1,1,,17389285,11883,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
138,588536,1,1,,26752941,11883,Inconclusive,216409692.0,5468.0,50.1187,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
139,588537,1,1,,17389285,11883,Inconclusive,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
140,588537,1,1,,26752941,11883,Active,216409692.0,5468.0,17.7828,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
141,588541,1,1,,17389285,11883,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
142,588541,1,1,,26752941,11883,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
143,588543,1,1,,17389285,11883,Inconclusive,216409708.0,7421.0,44.6684,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
144,588543,1,1,,26752941,11883,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
145,588544,1,1,,17389285,11883,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
146,588544,1,1,,26752941,11883,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
147,588545,1,1,,17389285,11883,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
148,588545,1,1,,26752941,11883,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
149,588546,1,1,,17389285,11883,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
150,588546,1,1,,26752941,11883,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
151,588547,1,1,,17389285,11883,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
152,588547,1,1,,26752941,11883,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
153,588812,1,1,,17389285,11883,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
154,588812,1,1,1.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
155,588812,1,1,2.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
156,588812,1,1,3.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
157,588812,1,1,4.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
158,588812,1,1,5.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
159,588812,1,1,6.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
160,588812,1,1,7.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
161,588812,1,1,8.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
162,588812,1,1,9.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
163,588812,1,1,10.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
164,588812,1,1,11.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
165,588812,1,1,12.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
166,588812,1,1,13.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
167,588812,1,1,14.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
168,588812,1,1,15.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
169,588812,1,1,16.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
170,588812,1,1,17.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
171,588812,1,1,18.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
172,588812,1,1,19.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
173,588812,1,1,20.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
174,588812,1,1,21.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
175,588812,1,1,22.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
176,588812,1,1,23.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
177,588812,1,1,24.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
178,588812,1,1,25.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
179,588812,1,1,26.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
180,588812,1,1,27.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
181,588812,1,1,28.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
182,588812,1,1,29.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
183,588812,1,1,30.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
184,588812,1,1,31.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
185,588812,1,1,32.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
186,588812,1,1,33.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
187,588812,1,1,34.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
188,588812,1,1,35.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
189,588812,1,1,36.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
190,588812,1,1,37.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
191,588812,1,1,38.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
192,588812,1,1,39.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
193,588812,1,1,40.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
194,588812,1,1,41.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
195,588812,1,1,42.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
196,588812,1,1,43.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
197,588812,1,1,44.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
198,588812,1,1,45.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
199,588812,1,1,46.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
200,588812,1,1,47.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
201,588812,1,1,48.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
202,588812,1,1,49.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
203,588812,1,1,50.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
204,588812,1,1,51.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
205,588812,1,1,52.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
206,588812,1,1,53.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
207,588812,1,1,54.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
208,588812,1,1,55.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
209,588812,1,1,56.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
210,588812,1,1,57.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
211,588812,1,1,58.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
212,588812,1,1,59.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
213,588812,1,1,60.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
214,588812,1,1,61.0,17389285,11883,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
215,588812,1,1,62.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
216,588812,1,1,63.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
217,588812,1,1,64.0,17389285,11883,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
218,588812,1,1,65.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
219,588812,1,1,66.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
220,588812,1,1,67.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
221,588812,1,1,68.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
222,588812,1,1,69.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
223,588812,1,1,70.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
224,588812,1,1,71.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
225,588812,1,1,72.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
226,588812,1,1,73.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
227,588812,1,1,74.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
228,588812,1,1,75.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
229,588812,1,1,76.0,17389285,11883,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
230,588812,1,1,77.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
231,588812,1,1,78.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
232,588812,1,1,79.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
233,588812,1,1,80.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
234,588812,1,1,81.0,17389285,11883,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
235,588813,1,1,,17389285,11883,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
236,588813,1,1,1.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
237,588813,1,1,2.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
238,588813,1,1,3.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
239,588813,1,1,4.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
240,588813,1,1,5.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
241,588813,1,1,6.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
242,588813,1,1,7.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
243,588813,1,1,8.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
244,588813,1,1,9.0,17389285,11883,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
245,588813,1,1,10.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
246,588813,1,1,11.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
247,588813,1,1,12.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
248,588813,1,1,13.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
249,588813,1,1,14.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
250,588813,1,1,15.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
251,588813,1,1,16.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
252,588813,1,1,17.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
253,588813,1,1,18.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
254,588813,1,1,19.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
255,588813,1,1,20.0,17389285,11883,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
256,588813,1,1,21.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
257,588813,1,1,22.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
258,588813,1,1,23.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
259,588813,1,1,24.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
260,588813,1,1,25.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
261,588813,1,1,26.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
262,588813,1,1,27.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
263,588813,1,1,28.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
264,588813,1,1,29.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
265,588813,1,1,30.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
266,588813,1,1,31.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
267,588813,1,1,32.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
268,588813,1,1,33.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
269,588813,1,1,34.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
270,588813,1,1,35.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
271,588813,1,1,36.0,17389285,11883,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
272,588813,1,1,37.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
273,588813,1,1,38.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
274,588813,1,1,39.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
275,588813,1,1,40.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
276,588813,1,1,41.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
277,588813,1,1,42.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
278,588813,1,1,43.0,17389285,11883,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
279,588813,1,1,44.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
280,588813,1,1,45.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
281,588813,1,1,46.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
282,588813,1,1,47.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
283,588813,1,1,48.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
284,588813,1,1,49.0,17389285,11883,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
285,588813,1,1,50.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
286,588813,1,1,51.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
287,588813,1,1,52.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
288,588813,1,1,53.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
289,588813,1,1,54.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
290,588813,1,1,55.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
291,588813,1,1,56.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
292,588813,1,1,57.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
293,588813,1,1,58.0,17389285,11883,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
294,588813,1,1,59.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
295,588813,1,1,60.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
296,588813,1,1,61.0,17389285,11883,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
297,588813,1,1,62.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
298,588813,1,1,63.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
299,588813,1,1,64.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
300,588813,1,1,65.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
301,588813,1,1,66.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
302,588813,1,1,67.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
303,588813,1,1,68.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
304,588813,1,1,69.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
305,588813,1,1,70.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
306,588813,1,1,71.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
307,588813,1,1,72.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
308,588813,1,1,73.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
309,588813,1,1,74.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
310,588813,1,1,75.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
311,588813,1,1,76.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
312,588813,1,1,77.0,17389285,11883,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
313,588813,1,1,78.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
314,588813,1,1,79.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
315,588813,1,1,80.0,17389285,11883,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
316,588813,1,1,81.0,17389285,11883,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
317,588834,2,1,,17389285,11883,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
318,651631,4,1,,144209357,11883,Inconclusive,269849759.0,7157.0,69.987,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
319,651631,4,1,,144213527,11883,Inconclusive,269849759.0,7157.0,68.5896,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
320,651632,4,1,,144209357,11883,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
321,651632,4,1,,144213527,11883,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
322,651633,4,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
323,651633,4,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
324,651634,4,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
325,651634,4,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
326,651741,1,1,,17389285,11883,Active,20149576.0,4780.0,13.3332,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
327,651741,1,1,,26752941,11883,Active,20149576.0,4780.0,8.6349,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
328,651743,1,1,,17389285,11883,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
329,651743,1,1,,26752941,11883,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
330,651749,1,1,,17389285,11883,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
331,651749,1,1,,26752941,11883,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
332,651751,1,1,,17389285,11883,Inconclusive,5702233.0,84385.0,56.2341,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
333,651751,1,1,,26752941,11883,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
334,651754,1,1,,17389285,11883,Inconclusive,,,53.0804,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
335,651755,1,1,,17389285,11883,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
336,651757,1,1,,17389285,11883,Inactive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
337,651758,1,1,,17389285,11883,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
338,651777,1,1,,17389285,11883,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
339,651777,1,1,,26752941,11883,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
340,651778,1,1,,17389285,11883,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
341,651778,1,1,,26752941,11883,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
342,651802,1,1,,17389285,11883,Inactive,49066040.0,6097.0,5.308,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
343,651838,1,1,,17389285,11883,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
344,651838,1,1,,26752941,11883,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
345,651838,1,1,1.0,17389285,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
346,651838,1,1,1.0,26752941,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
347,651838,1,1,2.0,17389285,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
348,651838,1,1,2.0,26752941,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
349,651838,1,1,3.0,17389285,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
350,651838,1,1,3.0,26752941,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
351,651838,1,1,4.0,17389285,11883,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
352,651838,1,1,4.0,26752941,11883,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
353,651838,1,1,5.0,17389285,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
354,651838,1,1,5.0,26752941,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
355,651838,1,1,6.0,17389285,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
356,651838,1,1,6.0,26752941,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
357,651838,1,1,7.0,17389285,11883,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
358,651838,1,1,7.0,26752941,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
359,651838,1,1,8.0,17389285,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
360,651838,1,1,8.0,26752941,11883,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
361,720516,2,1,,144209357,11883,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
362,720516,2,1,,144213527,11883,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
363,720552,2,1,,144209357,11883,Inconclusive,269849759.0,7157.0,78.5267,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
364,720552,2,1,,144213527,11883,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
365,720634,2,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
366,720634,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
367,720635,2,1,,144209357,11883,Active,,,62.376000000000005,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
368,720635,2,1,,144213527,11883,Active,,,61.1306,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
369,720636,1,1,,17389285,11883,Inconclusive,20149576.0,4780.0,29.8493,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
370,720636,1,1,,26752941,11883,Inconclusive,20149576.0,4780.0,48.5577,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
371,720637,2,1,,144209357,11883,Inconclusive,,,58.8867,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
372,720637,2,1,,144213527,11883,Inconclusive,,,61.1306,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
373,720652,1,1,,17389285,11883,Inconclusive,,,84.1267,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
374,720653,1,1,,17389285,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
375,720653,1,1,,26752941,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
376,720659,1,1,,17389285,11883,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
377,720659,1,1,,26752941,11883,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
378,720674,2,2,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
379,720674,2,2,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
380,720675,2,2,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
381,720675,2,2,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
382,720678,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
383,720678,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
384,720679,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
385,720679,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
386,720680,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
387,720680,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
388,720681,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
389,720681,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
390,720682,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
391,720682,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
392,720683,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
393,720683,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
394,720684,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
395,720684,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
396,720685,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
397,720685,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
398,720686,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
399,720686,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
400,720687,2,2,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
401,720687,2,2,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
402,720691,4,1,,144209357,11883,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
403,720691,4,1,,144213527,11883,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
404,720692,3,1,,144209357,11883,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
405,720692,3,1,,144213527,11883,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
406,720693,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
407,720693,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
408,720719,2,1,,144209357,11883,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
409,720719,2,1,,144213527,11883,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
410,720725,2,1,,144209357,11883,Active,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
411,720725,2,1,,144213527,11883,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
412,743012,3,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
413,743012,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
414,743014,3,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
415,743014,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
416,743015,3,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
417,743015,3,1,,144213527,11883,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
418,743033,3,1,,144209357,11883,Inconclusive,,,56.0992,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
419,743033,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
420,743035,2,1,,144209357,11883,Inconclusive,124375976.0,367.0,62.9443,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
421,743035,2,1,,144213527,11883,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
422,743036,2,1,,144209357,11883,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
423,743036,2,1,,144213527,11883,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
424,743040,3,1,,144209357,11883,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
425,743040,3,1,,144213527,11883,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
426,743041,3,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
427,743041,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
428,743042,3,1,,144209357,11883,Active,124375976.0,367.0,49.547,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
429,743042,3,1,,144213527,11883,Active,124375976.0,367.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
430,743053,2,1,,144209357,11883,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
431,743053,2,1,,144213527,11883,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
432,743054,2,1,,144209357,11883,Inconclusive,124375976.0,367.0,35.0766,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
433,743054,2,1,,144213527,11883,Active,124375976.0,367.0,43.2771,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
434,743063,2,1,,144209357,11883,Inconclusive,124375976.0,367.0,46.3045,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
435,743063,2,1,,144213527,11883,Inconclusive,124375976.0,367.0,48.9722,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
436,743064,3,1,,144209357,11883,Inconclusive,,,78.5267,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
437,743064,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
438,743065,3,1,,144209357,11883,Inconclusive,399498506.0,24831.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
439,743065,3,1,,144213527,11883,Inconclusive,399498506.0,24831.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
440,743066,3,1,,144209357,11883,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
441,743066,3,1,,144213527,11883,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
442,743067,2,1,,144209357,11883,Inconclusive,399498506.0,24831.0,69.987,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
443,743067,2,1,,144213527,11883,Inconclusive,399498506.0,24831.0,68.5896,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
444,743069,2,1,,144209357,11883,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
445,743069,2,1,,144213527,11883,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
446,743074,2,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
447,743074,2,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
448,743075,2,1,,144209357,11883,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
449,743075,2,1,,144213527,11883,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
450,743077,2,1,,144209357,11883,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
451,743077,2,1,,144213527,11883,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
452,743078,2,1,,144209357,11883,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
453,743078,2,1,,144213527,11883,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
454,743079,3,1,,144209357,11883,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
455,743079,3,1,,144213527,11883,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
456,743080,3,1,,144209357,11883,Inconclusive,348019627.0,2099.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
457,743080,3,1,,144213527,11883,Inactive,348019627.0,2099.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
458,743081,3,1,,144209357,11883,Inconclusive,,,78.5267,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
459,743081,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
460,743083,3,1,,144209357,11883,Inconclusive,119597822.0,1588.0,69.987,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
461,743083,3,1,,144213527,11883,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
462,743084,3,1,,144209357,11883,Active,,,62.376000000000005,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
463,743084,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
464,743085,3,1,,144209357,11883,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
465,743085,3,1,,144213527,11883,Inconclusive,51095037.0,196.0,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
466,743086,3,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
467,743086,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
468,743091,2,1,,144209357,11883,Inconclusive,348019627.0,2099.0,69.987,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
469,743091,2,1,,144213527,11883,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
470,743094,3,1,,144209357,11883,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
471,743094,3,1,,144213527,11883,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
472,743122,2,1,,144209357,11883,Inconclusive,51095037.0,196.0,44.1588,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
473,743122,2,1,,144213527,11883,Inconclusive,51095037.0,196.0,68.5896,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
474,743139,2,1,,144209357,11883,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
475,743139,2,1,,144213527,11883,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
476,743140,2,1,,144209357,11883,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
477,743140,2,1,,144213527,11883,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
478,743191,3,1,,144209357,11883,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
479,743191,3,1,,144213527,11883,Active,216409692.0,5468.0,6.9175,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
480,743194,3,1,,144209357,11883,Inconclusive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
481,743194,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
482,743199,2,1,,144209357,11883,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
483,743199,2,1,,144213527,11883,Active,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
484,743202,4,1,,144209357,11883,Inconclusive,20149576.0,4780.0,1.5668,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
485,743202,4,1,,144213527,11883,Inconclusive,20149576.0,4780.0,27.305999999999997,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
486,743203,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
487,743203,3,1,,144213527,11883,Inconclusive,,,76.9588,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
488,743209,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
489,743209,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
490,743210,4,1,,144209357,11883,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
491,743210,4,1,,144213527,11883,Inconclusive,4504517.0,3315.0,24.5442,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
492,743211,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
493,743211,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
494,743212,3,1,,144209357,11883,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
495,743212,3,1,,144213527,11883,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
496,743213,3,1,,144209357,11883,Inconclusive,,,62.9443,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
497,743213,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
498,743215,3,1,,144209357,11883,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
499,743215,3,1,,144213527,11883,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
500,743217,3,1,,144209357,11883,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
501,743217,3,1,,144213527,11883,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
502,743218,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
503,743218,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
504,743219,3,1,,144209357,11883,Active,20149576.0,4780.0,2.48323,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
505,743219,3,1,,144213527,11883,Active,20149576.0,4780.0,5.44827,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
506,743220,3,1,,144209357,11883,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
507,743220,3,1,,144213527,11883,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
508,743221,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
509,743221,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
510,743222,3,1,,144209357,11883,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
511,743222,3,1,,144213527,11883,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
512,743223,3,1,,144209357,11883,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
513,743223,3,1,,144213527,11883,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
514,743224,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
515,743224,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
516,743225,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
517,743225,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
518,743226,2,1,,144209357,11883,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
519,743226,2,1,,144213527,11883,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
520,743227,2,1,,144209357,11883,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
521,743227,2,1,,144213527,11883,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
522,743228,3,1,,144209357,11883,Inconclusive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
523,743228,3,1,,144213527,11883,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
524,743239,2,1,,144209357,11883,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
525,743239,2,1,,144213527,11883,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
526,743240,2,1,,144209357,11883,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
527,743240,2,1,,144213527,11883,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
528,743241,2,1,,144209357,11883,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
529,743241,2,1,,144213527,11883,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
530,743242,2,1,,144209357,11883,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
531,743242,2,1,,144213527,11883,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
532,743288,1,1,,17389285,11883,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
533,743288,1,1,,26752941,11883,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
534,743292,1,1,,17389285,11883,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
535,743292,1,1,,26752941,11883,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
536,1159509,1,1,,144209357,11883,Inconclusive,119626539.0,4790.0,56.0992,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
537,1159509,1,1,,144213527,11883,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
538,1159515,1,1,,144209357,11883,Inconclusive,,,56.0992,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
539,1159515,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
540,1159516,1,1,,144209357,11883,Inconclusive,119611100.0,22926.0,62.9443,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
541,1159516,1,1,,144213527,11883,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
542,1159517,1,1,,144209357,11883,Inconclusive,,,56.0992,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
543,1159517,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
544,1159518,1,1,,144209357,11883,Inconclusive,119626539.0,4790.0,59.4233,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
545,1159518,1,1,,144213527,11883,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
546,1159519,1,1,,144209357,11883,Inconclusive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
547,1159519,1,1,,144213527,11883,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
548,1159520,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
549,1159520,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
550,1159521,1,1,,144209357,11883,Active,15928672.0,19885.0,31.2621,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
551,1159521,1,1,,144213527,11883,Active,15928672.0,19885.0,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
552,1159523,1,1,,144209357,11883,Active,15928672.0,19885.0,27.8623,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
553,1159523,1,1,,144213527,11883,Inconclusive,15928672.0,19885.0,43.2771,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
554,1159525,1,1,,144209357,11883,Active,,,56.0992,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
555,1159525,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
556,1159526,1,1,,144209357,11883,Inconclusive,119627033.0,3725.0,44.5612,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
557,1159526,1,1,,144213527,11883,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
558,1159527,1,1,,144209357,11883,Inconclusive,325495497.0,6256.0,56.0992,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
559,1159527,1,1,,144213527,11883,Inconclusive,325495497.0,6256.0,48.9722,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
560,1159528,1,1,,144209357,11883,Inconclusive,119627033.0,3725.0,19.9047,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
561,1159528,1,1,,144213527,11883,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
562,1159529,1,1,,144209357,11883,Active,,,31.5469,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
563,1159529,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
564,1159531,1,1,,144209357,11883,Inconclusive,325495497.0,6256.0,19.9047,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
565,1159531,1,1,,144213527,11883,Inconclusive,325495497.0,6256.0,18.7622,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
566,1159551,1,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
567,1159551,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
568,1159552,1,1,,144209357,11883,Inconclusive,325495463.0,5914.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
569,1159552,1,1,,144213527,11883,Inconclusive,325495463.0,5914.0,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
570,1159553,2,1,,144209357,11883,Inconclusive,325495463.0,5914.0,15.6681,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
571,1159553,2,1,,144213527,11883,Inactive,325495463.0,5914.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
572,1159555,1,1,,144209357,11883,Inconclusive,325495463.0,5914.0,31.2621,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
573,1159555,1,1,,144213527,11883,Inconclusive,325495463.0,5914.0,61.1306,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
574,1224834,3,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
575,1224834,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
576,1224835,1,1,,144209357,11883,Inconclusive,160794.0,,64.605,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
577,1224835,1,1,,144213527,11883,Inconclusive,160794.0,,89.3584,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
578,1224836,1,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
579,1224836,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
580,1224837,1,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
581,1224837,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
582,1224838,1,1,,144209357,11883,Inactive,66775687.0,9970.0,8.8108,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
583,1224838,1,1,,144213527,11883,Inactive,66775687.0,9970.0,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
584,1224839,1,1,,144209357,11883,Inconclusive,66775687.0,9970.0,19.725,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
585,1224839,1,1,,144213527,11883,Active,66775687.0,9970.0,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
586,1224840,3,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
587,1224840,3,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
588,1224841,3,1,,144209357,11883,Active,325495545.0,2101.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
589,1224841,3,1,,144213527,11883,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
590,1224842,3,1,,144209357,11883,Inactive,325495545.0,2101.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
591,1224842,3,1,,144213527,11883,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
592,1224843,1,1,,144209357,11883,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
593,1224843,1,1,,144213527,11883,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
594,1224844,1,1,,144209357,11883,Inconclusive,,,62.9443,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
595,1224844,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
596,1224845,1,1,,144209357,11883,Inconclusive,344243002.0,100757539.0,115.419,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
597,1224845,1,1,,144213527,11883,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
598,1224846,1,1,,144209357,11883,Inconclusive,11995455.0,3091.0,56.0992,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
599,1224846,1,1,,144213527,11883,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
600,1224847,1,1,,144209357,11883,Inconclusive,,,129.502,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
601,1224847,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
602,1224848,3,1,,144209357,11883,Inconclusive,325495545.0,2101.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
603,1224848,3,1,,144213527,11883,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
604,1224849,3,1,,144209357,11883,Inactive,325495545.0,2101.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
605,1224849,3,1,,144213527,11883,Inactive,325495545.0,2101.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
606,1224867,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
607,1224867,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
608,1224868,1,1,,144209357,11883,Inconclusive,,,17.7401,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
609,1224868,1,1,,144213527,11883,Inconclusive,,,6.9175,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
610,1224869,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
611,1224869,1,1,,144213527,11883,Active,,,27.5391,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
612,1224870,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
613,1224870,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
614,1224871,1,1,,144209357,11883,Inconclusive,,,49.9985,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
615,1224871,1,1,,144213527,11883,Active,,,17.375999999999998,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
616,1224872,1,1,,144209357,11883,Inconclusive,,,19.9047,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
617,1224872,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
618,1224873,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
619,1224873,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
620,1224874,1,1,,144209357,11883,Inconclusive,,,15.8109,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
621,1224874,1,1,,144213527,11883,Inconclusive,,,17.375999999999998,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
622,1224875,1,1,,144209357,11883,Inconclusive,,,39.7152,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
623,1224875,1,1,,144213527,11883,Active,,,15.4864,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
624,1224876,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
625,1224876,1,1,,144213527,11883,Active,,,19.4962,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
626,1224877,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
627,1224877,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
628,1224878,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
629,1224878,1,1,,144213527,11883,Active,,,19.4962,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
630,1224879,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
631,1224879,1,1,,144213527,11883,Active,,,17.375999999999998,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
632,1224880,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
633,1224880,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
634,1224881,1,1,,144209357,11883,Inconclusive,,,49.9985,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
635,1224881,1,1,,144213527,11883,Active,,,15.4864,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
636,1224882,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
637,1224882,1,1,,144213527,11883,Active,,,27.5391,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
638,1224883,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
639,1224883,1,1,,144213527,11883,Active,,,19.4962,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
640,1224884,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
641,1224884,1,1,,144213527,11883,Active,,,15.4864,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
642,1224885,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
643,1224885,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
644,1224886,1,1,,144209357,11883,Inconclusive,,,17.7401,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
645,1224886,1,1,,144213527,11883,Inconclusive,,,6.9175,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
646,1224887,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
647,1224887,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
648,1224888,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
649,1224888,1,1,,144213527,11883,Active,,,15.4864,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
650,1224889,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
651,1224889,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
652,1224890,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
653,1224890,1,1,,144213527,11883,Active,,,15.4864,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
654,1224892,1,1,,144209357,11883,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
655,1224892,1,1,,144213527,11883,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
656,1224893,1,1,,144209357,11883,Inconclusive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
657,1224893,1,1,,144213527,11883,Inconclusive,66775687.0,9970.0,20.8733,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
658,1224894,1,1,,144209357,11883,Inconclusive,11995455.0,3091.0,56.0992,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
659,1224894,1,1,,144213527,11883,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
660,1224895,1,1,,144209357,11883,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
661,1224895,1,1,,144213527,11883,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
662,1224896,1,1,,144209357,11883,Inconclusive,344243002.0,100757539.0,14.5304,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
663,1224896,1,1,,144213527,11883,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
664,1259241,1,1,,144209357,11883,Active,,,62.376000000000005,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
665,1259241,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
666,1259242,1,1,,144209357,11883,Inconclusive,,,49.547,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
667,1259242,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
668,1259243,1,1,,144209357,11883,Active,124375976.0,367.0,24.8323,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
669,1259243,1,1,,144213527,11883,Active,124375976.0,367.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
670,1259244,1,1,,144209357,11883,Inconclusive,348019627.0,2099.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
671,1259244,1,1,,144213527,11883,Inactive,348019627.0,2099.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
672,1259247,1,1,,144209357,11883,Inconclusive,124375976.0,367.0,21.2986,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
673,1259247,1,1,,144213527,11883,Active,124375976.0,367.0,24.3365,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
674,1259248,1,1,,144209357,11883,Inconclusive,348019627.0,2099.0,31.2621,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
675,1259248,1,1,,144213527,11883,Inconclusive,348019627.0,2099.0,68.5896,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
676,1259364,1,1,,144209357,11883,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
677,1259364,1,1,,144213527,11883,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
678,1259365,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
679,1259365,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
680,1259366,1,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
681,1259366,1,1,,144213527,11883,Inconclusive,,,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
682,1259367,1,1,,144209357,11883,Active,,,49.547,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
683,1259367,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
684,1259368,1,1,,144209357,11883,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
685,1259368,1,1,,144213527,11883,Inactive,109731339.0,2737.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
686,1259369,1,1,,144209357,11883,Active,109731339.0,2737.0,22.1318,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
687,1259369,1,1,,144213527,11883,Active,109731339.0,2737.0,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
688,1259377,1,1,,144209357,11883,Inconclusive,54288833.0,2100.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
689,1259377,1,1,,144213527,11883,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
690,1259378,1,1,,144209357,11883,Inconclusive,54288833.0,2100.0,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
691,1259378,1,1,,144213527,11883,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
692,1259379,1,1,,144209357,11883,Active,,,62.376000000000005,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
693,1259379,1,1,,144213527,11883,Inconclusive,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
694,1259380,1,1,,144209357,11883,Active,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
695,1259380,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
696,1259381,1,1,,144209357,11883,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
697,1259381,1,1,,144213527,11883,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
698,1259382,1,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
699,1259382,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
700,1259383,1,1,,144209357,11883,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
701,1259383,1,1,,144213527,11883,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
702,1259384,1,1,,144209357,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
703,1259384,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
704,1259385,1,1,,144209357,11883,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
705,1259385,1,1,,144213527,11883,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
706,1259386,1,1,,144209357,11883,Inconclusive,,,69.987,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
707,1259386,1,1,,144213527,11883,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
708,1259387,1,1,,144209357,11883,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
709,1259387,1,1,,144213527,11883,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
710,1259388,1,1,,144209357,11883,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
711,1259388,1,1,,144213527,11883,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
712,1259390,1,1,,144209357,11883,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
713,1259390,1,1,,144213527,11883,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
714,1259391,1,1,,144209357,11883,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
715,1259391,1,1,,144213527,11883,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
716,1259392,1,1,,144209357,11883,Inconclusive,109731339.0,2737.0,17.5799,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
717,1259392,1,1,,144213527,11883,Active,109731339.0,2737.0,36.4132,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
718,1259393,1,1,,144209357,11883,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
719,1259393,1,1,,144213527,11883,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
720,1259394,1,1,,144209357,11883,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
721,1259394,1,1,,144213527,11883,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
722,1259395,1,1,,144209357,11883,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
723,1259395,1,1,,144213527,11883,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
724,1259396,1,1,,144209357,11883,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
725,1259396,1,1,,144213527,11883,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
726,1259401,1,1,,144209357,11883,Active,325495545.0,2101.0,66.072,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
727,1259401,1,1,,144213527,11883,Inconclusive,325495545.0,2101.0,8.63492,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
728,1259402,1,1,,144209357,11883,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
729,1259402,1,1,,144213527,11883,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
730,1259403,1,1,,144209357,11883,Inconclusive,325495545.0,2101.0,62.376000000000005,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
731,1259403,1,1,,144213527,11883,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
732,1259404,1,1,,144209357,11883,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
733,1259404,1,1,,144213527,11883,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
734,1259407,1,1,,363900789,11883,Inactive,,,,,CCRIS mutagenicity studies,Other,,
735,1259408,1,1,,363895806,11883,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
